Europe - BIT:1ISRG - US46120E6023 - Common Stock
The current stock price of 1ISRG.MI is 400.6 EUR. In the past month the price decreased by -10.51%.
Symbol | Company Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| ABL.DE | ABBOTT LABORATORIES | 25.46 | 190.51B | ||
| IUI1.DE | INTUITIVE SURGICAL INC | 68.18 | 169.63B | ||
| BSX.DE | BOSTON SCIENTIFIC CORP | 35.98 | 130.10B | ||
| 1MDT.MI | MEDTRONIC PLC | 17.39 | 106.40B | ||
| 2M6.DE | MEDTRONIC PLC | 16.85 | 103.08B | ||
| SHL.DE | SIEMENS HEALTHINEERS AG | 20.81 | 55.87B | ||
| BOX.DE | BECTON DICKINSON AND CO | 13.01 | 45.89B | ||
| EWL.DE | EDWARDS LIFESCIENCES CORP | 29.69 | 38.70B | ||
| PHI1.DE | KONINKLIJKE PHILIPS NV | 17.22 | 23.88B | ||
| PHIA.AS | KONINKLIJKE PHILIPS NV | 17.3 | 23.99B | ||
| DC4.DE | DEXCOM INC | 41.76 | 24.07B | ||
| QS51.DE | STRAUMANN HOLDING AG-REG | 34.12 | 15.51B |
Intuitive Surgical, Inc. engages in the provision of robotic-assisted surgical solutions and invasive care through a comprehensive ecosystem of products and services. The company is headquartered in Sunnyvale, California and currently employs 15,638 full-time employees. The company went IPO on 2000-06-13. The firm specializes in invasive care and robotic-assisted surgery. Its technologies include the da Vinci surgical systems and the Ion endoluminal system. The da Vinci surgical system is designed to enable surgeons to perform a range of surgical procedures within its targeted general surgery, urologic, gynecologic, cardiothoracic, and head and neck specialties and consists of a surgeon's console or consoles, a patient-side cart, and a high-performance vision system. The Ion endoluminal system is a flexible, robotic-assisted, catheter-based platform for which the cleared indication is minimally invasive biopsies in the lung and consists of a system cart, a controller, a catheter, and a vision probe. Its Ion system extends its commercial offering beyond surgery into diagnostic and endoluminal procedures.
INTUITIVE SURGICAL INC
1020 Kifer Road
Sunnyvale CALIFORNIA US
Employees: 15638
Phone: 14085232100
Intuitive Surgical, Inc. engages in the provision of robotic-assisted surgical solutions and invasive care through a comprehensive ecosystem of products and services. The company is headquartered in Sunnyvale, California and currently employs 15,638 full-time employees. The company went IPO on 2000-06-13. The firm specializes in invasive care and robotic-assisted surgery. Its technologies include the da Vinci surgical systems and the Ion endoluminal system. The da Vinci surgical system is designed to enable surgeons to perform a range of surgical procedures within its targeted general surgery, urologic, gynecologic, cardiothoracic, and head and neck specialties and consists of a surgeon's console or consoles, a patient-side cart, and a high-performance vision system. The Ion endoluminal system is a flexible, robotic-assisted, catheter-based platform for which the cleared indication is minimally invasive biopsies in the lung and consists of a system cart, a controller, a catheter, and a vision probe. Its Ion system extends its commercial offering beyond surgery into diagnostic and endoluminal procedures.
The current stock price of 1ISRG.MI is 400.6 EUR. The price increased by 6.7% in the last trading session.
1ISRG.MI does not pay a dividend.
1ISRG.MI has a ChartMill Technical rating of 1 out of 10 and a ChartMill Fundamental rating of 7 out of 10.
40 analysts have analysed 1ISRG.MI and the average price target is 513.31 EUR. This implies a price increase of 28.14% is expected in the next year compared to the current price of 400.6.
INTUITIVE SURGICAL INC (1ISRG.MI) operates in the Health Care sector and the Health Care Equipment & Supplies industry.
ChartMill assigns a technical rating of 1 / 10 to 1ISRG.MI.
ChartMill assigns a fundamental rating of 7 / 10 to 1ISRG.MI. Both the health and profitability get an excellent rating, making 1ISRG.MI a very profitable company, without any liquidiy or solvency issues.
Over the last trailing twelve months 1ISRG.MI reported a non-GAAP Earnings per Share(EPS) of 6.94. The EPS increased by 26.97% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | 28.51% | ||
| ROA | 12.93% | ||
| ROE | 14.61% | ||
| Debt/Equity | 0 |
40 analysts have analysed 1ISRG.MI and the average price target is 513.31 EUR. This implies a price increase of 28.14% is expected in the next year compared to the current price of 400.6.
For the next year, analysts expect an EPS growth of 13.54% and a revenue growth 19.76% for 1ISRG.MI